LivaNova (LIVN) Long-Term Deferred Tax (2015 - 2026)
LivaNova (LIVN) reported Long-Term Deferred Tax of $109.8 million for Q1 2026, little changed on a YoY basis from $109.5 million in Q1 2025, and down 1.05% sequentially from $111.0 million in Q4 2025.
LivaNova (LIVN) Long-Term Deferred Tax (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Long-Term Deferred Tax data on file, last reported at $109.8 million in Q1 2026.
- For the quarter ending Q1 2026, Long-Term Deferred Tax changed 0.33% year-over-year to $109.8 million; the trailing twelve-month figure through Mar 2026 stood at $109.8 million (changed 0.33% YoY), and the FY2025 full-year result was $111.0 million, down 0.78% from the prior year.
- Long-Term Deferred Tax fell to $109.8 million in Q1 2026, from $111.0 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $118.9 million in Q4 2023 to a low of $1.4 million in Q4 2022.
- A 5-year average of $66.3 million and a median of $109.5 million in 2025 frame the typical range for Long-Term Deferred Tax.
- Peak annual rise in Long-Term Deferred Tax reached 8488.01% in 2023, while the deepest fall reached 43.2% in 2023.
- Tracing LIVN's Long-Term Deferred Tax over 5 years: stood at $1.4 million in 2022, then surged by 8488.01% to $118.9 million in 2023, then declined by 5.89% to $111.9 million in 2024, then decreased by 0.78% to $111.0 million in 2025, then fell by 1.05% to $109.8 million in 2026.
- Business Quant data shows LIVN's Long-Term Deferred Tax at $109.8 million in Q1 2026, $111.0 million in Q4 2025, and $107.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.82 Mn |
| Dec 31, 2025 | 110.98 Mn |
| Sep 30, 2025 | 107.31 Mn |
| Jun 30, 2025 | 109.81 Mn |
| Mar 31, 2025 | 109.46 Mn |
| Dec 31, 2024 | 111.86 Mn |
| Sep 30, 2024 | 109.99 Mn |
| Jun 30, 2024 | 113.01 Mn |
| Mar 31, 2024 | 113.69 Mn |
| Dec 31, 2023 | 118.86 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 1.42 Mn |
| Jun 30, 2022 | 2.42 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Dec 31, 2021 | 2.20 Mn |
| Sep 30, 2021 | 2.01 Mn |
| Jun 30, 2021 | 1.88 Mn |